We are transforming cancer diagnostics by providing innovative, scalable, and low-cost solutions tailored for growing economies.
Problem
Cancer diagnostics are often too expensive, or they require equipment and specialization that is inaccessible in low- and middle-income countries.
Solution
A low cost, parsimonious gene expression assay that can be used in most laboratory settings to provide an accurate diagnosis without exp.
Publications
”Low-Cost, Transcriptional Diagnostic to Accurately Categorize Lymphomas in Low- and Middle-Income Countries” Full Manuscript: Blood Advances 2021 May 25;5(10):2447-2455. PMID: 33988700
Our Featured Work
